Pradefovir Mesylate
Tier C — Watch / tradePradefovir Mesylate
Targets：HBV pol
Indications (approved)：Chronic hepatitis B
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| PRADE-001 | 13422-80-5 | 3-(3-chlorophenyl)-3-oxopropanoic acid |
| PRADE-002 | 625095-57-0 | (S)-1-(3-chlorophenyl)propane-1,3-diol |
| PRADE-003 | 106941-25-7 | ((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid |
Frequently asked questions
What are the approved indications of Pradefovir Mesylate?
Approved indications include: Chronic hepatitis B.
When does the Pradefovir Mesylate patent expire?
No public expiry year is available for Pradefovir Mesylate yet; this page updates once verified.
How many synthesis routes are recorded for Pradefovir Mesylate?
1 synthesis routes are recorded; the shortest is 2 steps with 1.56 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Pradefovir Mesylate intermediates?
All intermediates in Pradefovir Mesylate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Pradefovir Mesylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29